| Design, synthesis and anticancer evaluation of new substituted thiophene-quinoline derivatives DIA Othman, KB Selim, AA Magda, AS Tantawy, Y Amen, K Shimizu, ... Bioorganic & Medicinal Chemistry 27 (19), 115026, 2019 | 39 | 2019 |
| Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies DIA Othman, A Hamdi, SS Tawfik, AA Elgazar, AS Mostafa Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2166037, 2023 | 22 | 2023 |
| Diazonaphthoquinones: synthesis, reactions and applications M Kitamura, DIA Othman Heterocycles 92 (10), 1761, 2016 | 22 | 2016 |
| Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis DIA Othman, A Hamdi, MM Abdel-Aziz, SM Elfeky Bioorganic Chemistry 124, 105809, 2022 | 15 | 2022 |
| Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2, 4-dione derivatives: histone deacetylases inhibitory activity and molecular docking … A Hamdi, WM Elhusseiny, DIA Othman, A Haikal, AH Bakheit, AS El-Azab, ... European Journal of Medicinal Chemistry 244, 114827, 2022 | 14 | 2022 |
| Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies A Hamdi, HW El-Shafey, DIA Othman, AS El-Azab, NA AlSaif, AM Alaa Bioorganic Chemistry 122, 105710, 2022 | 14 | 2022 |
| Total Synthesis of Eleuthoside A; Application of Rh-Catalyzed Intramolecular Cyclization of Diazonaphthoquinone DIA Othman, K Otsuka, S Takahashi, KB Selim, MA El-Sayed, AS Tantawy, ... Synlett 29 (04), 457-462, 2018 | 12 | 2018 |
| Novel benzofuran derivatives: synthesis and antitumor activity DI Othman, AMM Abdelal, MA El-Sayed, SAA El Bialy Heterocyclic Communications 19 (1), 29-35, 2013 | 12 | 2013 |
| Design and synthesis of benzene homologues tethered with 1, 2, 4-triazole and 1, 3, 4-thiadiazole motifs revealing dual MCF-7/HepG2 cytotoxic activity with prominent … M Alsehli, A Aljuhani, SK Ihmaid, SM El-Messery, DIA Othman, ... International Journal of Molecular Sciences 23 (15), 8796, 2022 | 10 | 2022 |
| Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: prospective targeted therapy HM Anter, RM Aman, DIA Othman, KM Elamin, IIA Hashim, MM Meshali International Journal of Pharmaceutics 631, 122536, 2023 | 9 | 2023 |
| Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity OA Abdelaziz, DIA Othman, MM Abdel-Aziz, SMI Badr, HM Eisa Bioorganic Chemistry 129, 106125, 2022 | 7 | 2022 |
| Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents MM Al-Sanea, A Hamdi, S Brogi, S S. Tawfik, DIA Othman, M Elshal, ... Journal of enzyme inhibition and medicinal chemistry 38 (1), 2162511, 2023 | 5 | 2023 |
| Development of new thiazolidine-2, 4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in … A Hamdi, M Yaseen, WA Ewes, MA Bhat, NI Ziedan, HW El-Shafey, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2231170, 2023 | 3 | 2023 |
| Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study DIA Othman, A Hamdi, WM Elhusseiny, AS El-Azab, AH Bakheit, ... Saudi Pharmaceutical Journal 31 (11), 101803, 2023 | 1 | 2023 |
| Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction MA Zeidan, DIA Othman, FE Goda, AS Mostafa Archiv der Pharmazie 357 (3), 2300320, 2024 | | 2024 |
| Thiazole ring-cleavage: Versatile products obtained in the course of synthesis of certain sulfonamide derivatives MA Zeidan, DIA Othman, FE Goda, AS Mostafa Journal of Molecular Structure 1279, 135018, 2023 | | 2023 |
| Thiazolopyrimidine as a Promising Anticancer Pharmacophore: In Silico Drug Design, Molecular Docking and ADMET Prediction Studies OA El-Khouly, DIA Othman, AS Mostafa, MA Massoud Medical Sciences Forum 14 (1), 4, 2022 | | 2022 |
